From plasma rich with antibodies from recovered Coronavirus patients
Hadassah Hospital in Jerusalem on the 23d of June 2020 became the first site in the world to test a passive vaccine treatment for Coronavirus (COVID-19) by administering Immunoglobulin G (IgG).
Two months ago, the Hadassah Medical Center started collecting plasma rich with antibodies from recovered Coronavirus patients, with the aim of producing a treatment for severely ill patients. The plasmas collected from the recovered patients were processed by the Kamada company at Kibbutz Beit Kama in the Negev for an IgG-based antibody treatment for Corona patients in severe conditions. Kamada, which develops and manufactures plasma-based drugs, has completed the production of the first dose of human plasma-based corona treatment for COVID-19, a move that has sparked widespread international interest.
Representing approximately 75% of serum antibodies in humans, IgG is the most common type of antibody found in blood circulation.
Hadassah administered the world’s first passive vaccine to a seriously ill patient, a young woman with previous illnesses whose CT results showed completely white lungs, and all known treatment methods have not affected her condition. Several hours after receiving the treatment, the patient’s condition appears to have stabilized, giving room for cautious optimism.
The venture is operating with the approval of the Ministry of Health of Israel and in cooperation with Magen David Adom. Hadassah CEO Professor Ze’ev Rothstein stated that the hospital is “crossing its fingers” for the success of the treatment and thanked everyone who took part in this “complex operation.”
For more than 110 years, Hadassah University Hospital in Jerusalem (www.hadassah-med.com) has been a leader in medicine and nursing in Israel, laying the foundation and setting the standards for the country's modern health care system. The majority of medical breakthroughs in Israel have taken place there. With more than 130 departments and clinics, Hadassah-Ein Kerem provides Israel's most advanced diagnostic and therapeutic services for the local and national population and a significant number of international patients.
iMER (International Medical Evaluation and Referrals) is a Worldwide Health Services Provider and the exclusive representative of Hadassah University Hospital in Greece and Cyprus, offering healthcare services in the most technologically and medically advanced centers in Israel and treatments that cannot be found elsewhere, by medical scientists that are pioneers in their field of specialization.